The WACC of Annexin Pharmaceuticals AB (publ) (ANNX.ST) is .
| Range | Selected | |
| Cost of equity | - | |
| Tax rate | - | |
| Cost of debt | - | |
| WACC | - |
| Category | Low | High |
| Long-term bond rate | ||
| Equity market risk premium | ||
| Adjusted beta | ||
| Additional risk adjustments | ||
| Cost of equity | ||
| Tax rate | ||
| Debt/Equity ratio | ||
| Cost of debt | ||
| After-tax WACC | ||
| Selected WACC | ||